Smoking and development of type 2 diabetes in patients with decreased functional capacity
- 10 October 2005
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 104 (3) , 275-281
- https://doi.org/10.1016/j.ijcard.2004.10.034
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Peroxisome Proliferator–Activated Receptor Ligand Bezafibrate for Prevention of Type 2 Diabetes Mellitus in Patients With Coronary Artery DiseaseCirculation, 2004
- Definition of Metabolic SyndromeCirculation, 2004
- Cigarette Smoking is Independently Associated with Markers of Endothelial Dysfunction and Hyperinsulinaemia in Non-diabetic Individuals with Coronary Artery DiseaseCurrent Medical Research and Opinion, 2001
- Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failurePublished by Oxford University Press (OUP) ,2000
- Can Sustained Weight Loss in Overweight Individuals Reduce the Risk of Diabetes Mellitus?Epidemiology, 2000
- Diabetes mellitus and congestive heart failureEuropean Heart Journal, 1999
- Smoking Is Independently Associated With High Plasma Insulin Levels in Nondiabetic MenDiabetes Care, 1996
- Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the bezafibrate infarction prevention trial)The American Journal of Cardiology, 1993
- Insulin resistance and cigarette smokingThe Lancet, 1992
- Physical activity and incidence of non-insulin-dependent diabetes mellitus in womenThe Lancet, 1991